More recently, one antigen-specific therapy utilized GAD65 in combination with aluminum hydroxide and took advantage of alum’s Th2-biased adjuvant property, thereby modulating pathological Th1 autoimmunity by redirecting the dominant Th1 response to the Th2 response (40). Here, GAD2 is linked to Autoimmunity.